BTC $71,807
2026 Bull Run Is Building Start trading with 5% OFF all fees
Sign Up Now
BTC $71,807
Bull Run 2026 | 5% Off Fees Open your Binance account today
Sign Up

Trump Administration Eyes Grants to Boost U.S. Generic Drug Output

Trump Reverses Course on Tariffs for Generic Drugs Following White House Dispute Over Costs and Supply: Report

  • The U.S. administration does not plan to implement tariffs on generic drugs.
  • Section 232 tariffs under the Trade Expansion Act are still being considered for branded medicines.
  • Officials are exploring loans or grants to boost domestic generic drug manufacturing.
  • Concerns about possible price hikes and shortages from tariffs influenced the decision.
  • Nearly half of U.S. generics are sourced from India, highlighting reliance on foreign suppliers.

The U.S. administration has decided against imposing tariffs on generic pharmaceuticals, according to statements provided by a White House spokesperson. This follows months of internal discussions regarding the potential use of tariffs under Section 232 of the Trade Expansion Act, which allows such measures on national security grounds.

- Advertisement -

Earlier, there were proposals for a 100% tariff on name-brand drugs, initially set to begin on October 1, but generic drugs were excluded from this plan. More recently, the move was postponed to allow for further negotiations, as reported by The Wall Street Journal. Commerce Department officials confirmed that there are currently no plans to apply tariffs to generic medications.

White House spokesperson Kush Desai stated, “The administration is not actively discussing imposing Section 232 tariffs against generic pharmaceuticals.” The Commerce Department, leading the investigation, echoed this position. Desai further explained that the administration is taking “a nuanced and multi-faceted approach to onshore manufacturing of generic pharmaceuticals” in order to reduce reliance on overseas production.

Throughout policy discussions, some administration members warned that tariffs on generic medicines, many produced in India, could lead to higher prices and supply disruptions. India supplies almost half of the generic drugs dispensed in the United States. In response to these concerns, officials are also looking at options like federal grants or low-interest loans to encourage U.S.-based production, possibly using funds from tariff arrangements with allied countries such as Japan.

Analysts have cited disruptions during the COVID-19 pandemic as evidence of vulnerabilities in pharmaceutical supply chains. The administration has faced pressure from supporters of reshoring critical industries, though some protectionist lawmakers continue to advocate for broader tariff use. Trade officials said they are reviewing which economic strategies could best support domestic manufacturing, as generic drugs currently face few import restrictions.

- Advertisement -

Previous Articles:

- Advertisement -
Ad
Altseason Is Loading. Don't watch from the sidelines.
SOL $90.51
DOGE $0.0963
LINK $9.02
SUI $1.00
5% off fees when you sign up
Start Trading
Ad
Pay Less on Every Trade. For Life.
$10K/mo volume Save $60/yr
$50K/mo volume Save $300/yr
$100K/mo volume Save $600/yr
5% off all trading fees when you sign up
Claim Your Discount

Latest News

ImmunityBio founder touts sepsis trials, NantX after Binance theft

Patrick Soon-Shiong renewed his “NantX coming soon” teaser after a $6.3 billion Binance theft,...

Crypto.com Shuts Hong Kong App, Eyes Institutional Exchange

crypto.com will shut down its consumer app in Hong Kong on Feb. 1, 2027,...

Kim Yo Jong denies North Korea behind Binance hack, hints US

Kim Yo Jong denied North Korea's involvement in the $6.3 billion Binance hack and...

Strive buys 124 BTC, fourth among public companies

Strive acquired 124 Bitcoin for roughly $10 million between Oct. 24 and Oct. 30,...

Claude finds 9.8 zero-click Linux root bug

Claude discovered a zero-click Linux vulnerability (CVE-2026-98432) rated 9.8 out of 10, described as...

Must Read

6 Best VPN Providers That Accept Monero

Privacy and anonymity are probably the most important things that we should all consider in today's internet era. Although there are a lot of...
Ad
Altseason Is Loading. These 4 coins are trending right now.
SOL $92.12
DOGE $0.0950
LINK $9.02
SUI $1.02
5% off spot fees when you sign up
Start Trading